Breaking News Instant updates and real-time market news.

YCBD

cbdMD

$2.08 /

-0.08 (-3.70%)

09:24
11/05/20
11/05
09:24
11/05/20
09:24

cbdMD seeks to obtain regulatory approval from UK's FSA

cbdMD confirmed today that it is on track to submit its Novel Foods Dossier with the United Kingdom's Food Safety Agency, FSA, by the required regulatory filing deadline of March 31, 2021. "By allowing CBD product manufacturers to obtain a Novel Food Authorization from the FSA, the UK is now leading the world in CBD regulation. cbdMD believes it's in a unique position to demonstrate the safety of its products to the FSA and therefore we believe will be one of the few CBD companies that will be allowed to continue to sell their CBD products on UK's retail store shelves after the March 31, 2021 deadline. We know that major UK retailers have delayed new CBD product introductions until CBD brands are cleared by the FSA. cbdMD believes if it is successful in obtaining FSA approval, it will have a competitive advantage and therefore a significant opportunity for brand expansion in the UK market. We believe that the expected successful completion of this regulatory approval process provides cbdMD a valuable tool as we continue to prepare for other regulatory approvals around the world," said Chief Marketing Officer, Ken Cohn. cbdMD is working in conjunction with a leading food safety and regulatory consultant in the UK to prepare the dossier which will include detailed analysis of the quality and stability of our product, our hemp sourcing and extraction controls, our labelling and testing requirements, and the underlying intake and toxicological data related to the safe consumption of the proprietary cannabinoid blend ingredients in our cbdMD product line. cbdMD believes this step is important as a precursor for its preparation of its EU and FDA NDIN submissions

  • 09

    Dec

  • 10

    Jan

YCBD cbdMD
$2.08 /

-0.08 (-3.70%)

03/09/20 Cantor Fitzgerald
cbdMD price target lowered to $1.20 from $3.40 at Cantor Fitzgerald
11/07/19 Cantor Fitzgerald
Cantor Fitzgerald expects industry consolidation in consumer CBD wellness trend
11/07/19 Cantor Fitzgerald
cbdMD initiated with a Neutral at Cantor Fitzgerald

TODAY'S FREE FLY STORIES

Periodicals
JPMorgan tells staff they may be required to get vaccinated, Bloomberg says  19:22
06/23/21
06/23
19:22
06/23/21
19:22
JPM

JPMorgan

$151.12 /

+0.91 (+0.61%)

 
ShowHide Related Items >><<
JPM JPMorgan
$151.12 /

+0.91 (+0.61%)

JPM JPMorgan
$151.12 /

+0.91 (+0.61%)

06/15/21 BMO Capital
JPMorgan price target trimmed to $139 at BMO Capital on reduced NII view
06/14/21 Evercore ISI
Synchrony price target raised to $56 from $49 at Evercore ISI
06/08/21 Wells Fargo
JPMorgan price target raised to $200 from $195 at Wells Fargo
05/06/21 JMP Securities
Walker & Dunlop price target raised to $130 from $70 at JMP Securities
JPM JPMorgan
$151.12 /

+0.91 (+0.61%)

JPM JPMorgan
$151.12 /

+0.91 (+0.61%)

JPM JPMorgan
$151.12 /

+0.91 (+0.61%)

JPM JPMorgan
$151.12 /

+0.91 (+0.61%)

Upgrade
GlaxoSmithKline upgraded to Hold from Sell at Deutsche Bank » 19:21
06/23/21
06/23
19:21
06/23/21
19:21
GSK

GlaxoSmithKline

$39.86 /

+0.78 (+2.00%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GSK GlaxoSmithKline
$39.86 /

+0.78 (+2.00%)

GSK GlaxoSmithKline
$39.86 /

+0.78 (+2.00%)

06/14/21 Piper Sandler
iTeos deal 'addresses a number of needs all at once, says Piper Sandler
06/11/21 Deutsche Bank
GlaxoSmithKline price target raised to 1,300 GBp at Deutsche Bank
05/27/21 Piper Sandler
Xencorc royalty revenue streams growing, says Piper Sandler
05/11/21 UBS
GlaxoSmithKline price target raised to 1,370 GBp from 1,360 GBp at UBS
GSK GlaxoSmithKline
$39.86 /

+0.78 (+2.00%)

GSK GlaxoSmithKline
$39.86 /

+0.78 (+2.00%)

GSK GlaxoSmithKline
$39.86 /

+0.78 (+2.00%)

GSK GlaxoSmithKline
$39.86 /

+0.78 (+2.00%)

Hot Stocks
Japan's PMDA renews Certara's biosimulation software license » 19:03
06/23/21
06/23
19:03
06/23/21
19:03
CERT

Certara

$26.38 /

-0.81 (-2.98%)

Certara announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CERT Certara
$26.38 /

-0.81 (-2.98%)

CERT Certara
$26.38 /

-0.81 (-2.98%)

05/07/21 Barclays
Certara price target lowered to $35 from $40 at Barclays
03/02/21 Barclays
Certara initiated with an Overweight at Barclays
03/02/21 Barclays
Certara initiated with an Overweight at Barclays
01/05/21 Morgan Stanley
Morgan Stanley starts Certara at Equal Weight, says fully valued
CERT Certara
$26.38 /

-0.81 (-2.98%)

  • 25
    Mar
  • 11
    Dec
CERT Certara
$26.38 /

-0.81 (-2.98%)

CERT Certara
$26.38 /

-0.81 (-2.98%)

On The Fly
Fly Intel: After-Hours Movers » 18:58
06/23/21
06/23
18:58
06/23/21
18:58
SCS

Steelcase

$14.49 /

+0.04 (+0.28%)

, RCUS

Arcus Biosciences

$23.40 /

+0.67 (+2.95%)

, FSP

Franklin Street

$5.27 /

-0.13 (-2.41%)

, KBH

KB Home

$43.35 /

+0.1 (+0.23%)

, CNXC

Concentrix

$157.11 /

+2.23 (+1.44%)

, FUL

H.B. Fuller

$65.62 /

-0.885 (-1.33%)

, PRTG

Portage Biotech

$35.28 /

+2.38 (+7.23%)

, BNL

Broadstone Net Lease

$24.08 /

+0.37 (+1.56%)

, TALO

Talos Energy

$18.60 /

+0.47 (+2.59%)

, BYND

Beyond Meat

$147.37 /

-0.47 (-0.32%)

Check out this evening's…

ShowHide Related Items >><<
SCS Steelcase
$14.49 /

+0.04 (+0.28%)

RCUS Arcus Biosciences
$23.40 /

+0.67 (+2.95%)

FSP Franklin Street
$5.27 /

-0.13 (-2.41%)

KBH KB Home
$43.35 /

+0.1 (+0.23%)

CNXC Concentrix
$157.11 /

+2.23 (+1.44%)

FUL H.B. Fuller
$65.62 /

-0.885 (-1.33%)

BNL Broadstone Net Lease
$24.08 /

+0.37 (+1.56%)

TALO Talos Energy
$18.60 /

+0.47 (+2.59%)

BYND Beyond Meat
$147.37 /

-0.47 (-0.32%)

SCS Steelcase
$14.49 /

+0.04 (+0.28%)

05/11/21 Berenberg
Berenberg starts 'market leader' Steelcase at Buy
05/11/21 Berenberg
Steelcase initiated with a Buy at Berenberg
05/07/21 Benchmark
Benchmark upgrades Steelcase to Buy on signs of recovery in commercial furniture
05/07/21 Benchmark
Steelcase upgraded to Buy from Hold at Benchmark
RCUS Arcus Biosciences
$23.40 /

+0.67 (+2.95%)

02/25/21 Barclays
Arcus Biosciences price target raised to $45 from $40 at Barclays
02/25/21 Mizuho
Arcus Biosciences price target raised to $43 from $40 at Mizuho
01/20/21 Citi
Arcus Biosciences price target raised to $51 from $32 at Citi
01/19/21 Wedbush
Arcus Biosciences price target raised to $55 from $48 at Wedbush
FSP Franklin Street
$5.27 /

-0.13 (-2.41%)

KBH KB Home
$43.35 /

+0.1 (+0.23%)

06/15/21 Wedbush
Wedbush sees pullback in KB Home shares as buying opportunity
04/15/21 Wells Fargo
KB Home initiated with an Overweight at Wells Fargo
03/29/21 Argus
KB Home's new orders were 'stellar', says Argus
03/25/21 Keefe Bruyette
KB Home price target raised to $48 from $44 at Keefe Bruyette
CNXC Concentrix
$157.11 /

+2.23 (+1.44%)

06/15/21 Barrington
Concentrix initiated with an Outperform at Barrington
01/07/21 Cross Research
Concentrix initiated with a Buy at Cross Research
12/08/20 Stifel
Synnex downgraded to Hold from Buy at Stifel
12/07/20 BofA
Concentrix initiated with a Buy at BofA
FUL H.B. Fuller
$65.62 /

-0.885 (-1.33%)

03/29/21 Deutsche Bank
H.B. Fuller price target raised to $65 from $56 at Deutsche Bank
03/26/21 Baird
H.B. Fuller price target raised to $72 from $65 at Baird
01/27/21 Deutsche Bank
H.B. Fuller price target raised to $56 from $48 at Deutsche Bank
01/04/21 Baird
H.B. Fuller upgraded to Outperform, added to 2021 top picks at Baird
PRTG Portage Biotech
$35.28 /

+2.38 (+7.23%)

BNL Broadstone Net Lease
$24.08 /

+0.37 (+1.56%)

06/22/21 BTIG
Broadstone Net Lease price target raised to $27 from $21 at BTIG
06/17/21 Goldman Sachs
Broadstone Net Lease downgraded to Neutral from Buy at Goldman Sachs
06/15/21
Fly Intel: Top five analyst downgrades
06/15/21 JPMorgan
JPMorgan upgrades W.P. Carey on swap out of Broadstone
TALO Talos Energy
$18.60 /

+0.47 (+2.59%)

06/08/21
Fly Intel: Top five analyst initiations
06/08/21 Citi
Talos Energy initiated with a Buy at Citi
05/03/21 Roth Capital
Talos Energy price target raised to $18 from $13 at Roth Capital
04/13/21 Stifel
BP discovery holds over 100MMboe of potential net to Talos interest, says Stifel
BYND Beyond Meat
$147.37 /

-0.47 (-0.32%)

16:11 Today JPMorgan
Beyond Meat breakfast sandwich discontinued at Dunkin', says JPMorgan
05/24/21
Fly Intel: Top five analyst upgrades
05/24/21 Bernstein
Beyond Meat upgraded to Outperform from Underperform at Bernstein
05/11/21 Barclays
Beyond Meat price target lowered to $90 from $100 at Barclays
SCS Steelcase
$14.49 /

+0.04 (+0.28%)

RCUS Arcus Biosciences
$23.40 /

+0.67 (+2.95%)

KBH KB Home
$43.35 /

+0.1 (+0.23%)

CNXC Concentrix
$157.11 /

+2.23 (+1.44%)

FUL H.B. Fuller
$65.62 /

-0.885 (-1.33%)

BNL Broadstone Net Lease
$24.08 /

+0.37 (+1.56%)

TALO Talos Energy
$18.60 /

+0.47 (+2.59%)

BYND Beyond Meat
$147.37 /

-0.47 (-0.32%)

  • 24
    Jun
  • 24
    Jun
  • 24
    Jun
  • 09
    Dec
  • 17
    Sep
KBH KB Home
$43.35 /

+0.1 (+0.23%)

TALO Talos Energy
$18.60 /

+0.47 (+2.59%)

BYND Beyond Meat
$147.37 /

-0.47 (-0.32%)

SCS Steelcase
$14.49 /

+0.04 (+0.28%)

KBH KB Home
$43.35 /

+0.1 (+0.23%)

FUL H.B. Fuller
$65.62 /

-0.885 (-1.33%)

TALO Talos Energy
$18.60 /

+0.47 (+2.59%)

BYND Beyond Meat
$147.37 /

-0.47 (-0.32%)

SCS Steelcase
$14.49 /

+0.04 (+0.28%)

KBH KB Home
$43.35 /

+0.1 (+0.23%)

CNXC Concentrix
$157.11 /

+2.23 (+1.44%)

FUL H.B. Fuller
$65.62 /

-0.885 (-1.33%)

BYND Beyond Meat
$147.37 /

-0.47 (-0.32%)

Hot Stocks
IGC completes final cohort of Phase 1 trial on Alzheimer's patients » 18:54
06/23/21
06/23
18:54
06/23/21
18:54
IGC

India Globalization Capital

$1.46 /

-0.01 (-0.68%)

India Globalization…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IGC India Globalization Capital
$1.46 /

-0.01 (-0.68%)

IGC India Globalization Capital
$1.46 /

-0.01 (-0.68%)

03/29/21 Stifel
Stifel says New York adult use cannabis market represents $5B opportunity
02/02/21 Craig-Hallum
Legalization could drive '3x upside' for U.S. cannabis stocks, says Craig-Hallum
01/29/21 Stifel
'Goldilocks' scenario for U.S. cannabis industry in play, says Stifel
12/04/20 Alliance Global Partners
Alliance Global sees low odds of MORE Act passing this congressional session
IGC India Globalization Capital
$1.46 /

-0.01 (-0.68%)

IGC India Globalization Capital
$1.46 /

-0.01 (-0.68%)

IGC India Globalization Capital
$1.46 /

-0.01 (-0.68%)

Hot Stocks
Box CEO: We're executing a very effective strategy » 18:48
06/23/21
06/23
18:48
06/23/21
18:48
BOX

Box

$25.22 /

+0.02 (+0.08%)

In an interview on…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BOX Box
$25.22 /

+0.02 (+0.08%)

BOX Box
$25.22 /

+0.02 (+0.08%)

04/09/21 DA Davidson
Box price target lowered to $22 from $25 at DA Davidson
04/09/21 William Blair
KKR investment 'strong vote of confidence' in Box, says William Blair
04/09/21 William Blair
KKR investment 'strong vote of confidence' in Box, says William Blair
03/23/21 KeyBanc
Box price target raised to $27 from $22 at KeyBanc
BOX Box
$25.22 /

+0.02 (+0.08%)

BOX Box
$25.22 /

+0.02 (+0.08%)

BOX Box
$25.22 /

+0.02 (+0.08%)

BOX Box
$25.22 /

+0.02 (+0.08%)

Hot Stocks
J.M. Smucker CEO sells 10K shares of common stock » 18:44
06/23/21
06/23
18:44
06/23/21
18:44
SJM

J.M. Smucker

$129.06 /

-1.42 (-1.09%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SJM J.M. Smucker
$129.06 /

-1.42 (-1.09%)

SJM J.M. Smucker
$129.06 /

-1.42 (-1.09%)

06/04/21 Stifel
J.M. Smucker price target raised to $135 from $125 at Stifel
06/04/21 Deutsche Bank
J.M. Smucker price target raised to $140 from $138 at Deutsche Bank
06/04/21 BofA
J.M. Smucker price target raised to $140 from $124 at BofA
05/20/21 Deutsche Bank
J.M. Smucker named 'Catalyst Call: Buy Idea' at Deutsche Bank
SJM J.M. Smucker
$129.06 /

-1.42 (-1.09%)

SJM J.M. Smucker
$129.06 /

-1.42 (-1.09%)

SJM J.M. Smucker
$129.06 /

-1.42 (-1.09%)

SJM J.M. Smucker
$129.06 /

-1.42 (-1.09%)

Upgrade
Magna upgraded to Buy from Neutral at Goldman Sachs » 18:42
06/23/21
06/23
18:42
06/23/21
18:42
MGA

Magna

$92.86 /

+0.24 (+0.26%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MGA Magna
$92.86 /

+0.24 (+0.26%)

MGA Magna
$92.86 /

+0.24 (+0.26%)

06/21/21 Edward Jones
Magna upgraded to Buy from Hold at Edward Jones
05/31/21 BMO Capital
Magna price target raised to $115 from $108 at BMO Capital
05/10/21 Credit Suisse
Magna price target raised to $120 from $115 at Credit Suisse
04/20/21 Morgan Stanley
Fisker remains 'top ranked' EV related SPAC startup, says Morgan Stanley
MGA Magna
$92.86 /

+0.24 (+0.26%)

MGA Magna
$92.86 /

+0.24 (+0.26%)

MGA Magna
$92.86 /

+0.24 (+0.26%)

MGA Magna
$92.86 /

+0.24 (+0.26%)

Recommendations
Patterson Companies price target lowered to $41 from $44 at Piper Sandler » 18:39
06/23/21
06/23
18:39
06/23/21
18:39
PDCO

Patterson Companies

$30.95 /

-4.18 (-11.90%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PDCO Patterson Companies
$30.95 /

-4.18 (-11.90%)

PDCO Patterson Companies
$30.95 /

-4.18 (-11.90%)

08:42 Today Piper Sandler
Patterson earnings pullback a buying opportunity, says Piper Sandler
06/17/21
Fly Intel: Top five analyst upgrades
06/17/21 Piper Sandler
Patterson Companies upgraded to Overweight from Neutral at Piper Sandler
03/03/21 Piper Sandler
Piper stays Neutral Patterson despite execution due to 'lingering uncertainty'
PDCO Patterson Companies
$30.95 /

-4.18 (-11.90%)

PDCO Patterson Companies
$30.95 /

-4.18 (-11.90%)

Periodicals
BuzzFeed close to go-public deal with 890 5th Avenue Partners, WSJ reports » 18:11
06/23/21
06/23
18:11
06/23/21
18:11
ENFA

890 5th Avenue Partners

$9.79 /

-0.01 (-0.10%)

BuzzFeed is nearing a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ENFA 890 5th Avenue Partners
$9.79 /

-0.01 (-0.10%)

ENFA 890 5th Avenue Partners
$9.79 /

-0.01 (-0.10%)

Syndicate
Doximity 23.3M share IPO priced at $26.00 » 18:05
06/23/21
06/23
18:05
06/23/21
18:05
DOCS

Doximity

/

+

The deal priced above the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
  • 24
    Jun
Syndicate
Confluent 23M share IPO priced at $36.00 » 18:04
06/23/21
06/23
18:04
06/23/21
18:04
CFLT

Confluent

/

+

The deal priced above the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
  • 24
    Jun
Syndicate
Portage Biotech files to sell common stock, no amount given » 17:50
06/23/21
06/23
17:50
06/23/21
17:50
PRTG

Portage Biotech

$35.28 /

+2.38 (+7.23%)

Cantor Fitzgerald and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
  • 24
    Jun
Initiation
PayPal initiated with a Buy at DA Davidson » 17:49
06/23/21
06/23
17:49
06/23/21
17:49
PYPL

PayPal

$288.11 /

+1.22 (+0.43%)

DA Davidson initiated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PYPL PayPal
$288.11 /

+1.22 (+0.43%)

PYPL PayPal
$288.11 /

+1.22 (+0.43%)

12:16 Today Credit Suisse
PayPal pricing update raises confidence in five-year outlook, says Credit Suisse
06/21/21 BofA
PayPal's announced price increase already in guidance, says BofA
06/21/21 Barclays
PayPal price increase to bring 2022 earnings upside, says Barclays
05/07/21 BMO Capital
PayPal price target raised to $256 from $241 at BMO Capital
PYPL PayPal
$288.11 /

+1.22 (+0.43%)

PYPL PayPal
$288.11 /

+1.22 (+0.43%)

PYPL PayPal
$288.11 /

+1.22 (+0.43%)

PYPL PayPal
$288.11 /

+1.22 (+0.43%)

Initiation
Square initiated with a Buy at DA Davidson » 17:38
06/23/21
06/23
17:38
06/23/21
17:38
SQ

Square

$238.66 /

+2.68 (+1.14%)

DA Davidson analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SQ Square
$238.66 /

+2.68 (+1.14%)

SQ Square
$238.66 /

+2.68 (+1.14%)

05/25/21 Baird
Square comps starting to get more difficult, says Baird
05/20/21 Tigress Financial
Square shares have close to 50% upside potential, says Tigress Financial
05/10/21 BMO Capital
Square price target raised to $269 from $237 at BMO Capital
05/07/21 JPMorgan
Square price target raised to $300 from $250 at JPMorgan
SQ Square
$238.66 /

+2.68 (+1.14%)

SQ Square
$238.66 /

+2.68 (+1.14%)

SQ Square
$238.66 /

+2.68 (+1.14%)

SQ Square
$238.66 /

+2.68 (+1.14%)

Conference/Events
G-III Apparel participates in a conference call with UBS » 17:38
06/23/21
06/23
17:38
06/23/21
17:38
GIII

G-III Apparel

$32.57 /

+0.53 (+1.65%)

Consumer Goods Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GIII G-III Apparel
$32.57 /

+0.53 (+1.65%)

GIII G-III Apparel
$32.57 /

+0.53 (+1.65%)

06/08/21 B. Riley
G-III Apparel price target raised to $41 from $39 at B. Riley
06/08/21 Barclays
G-III Apparel price target raised to $30 from $27 at Barclays
03/19/21 B. Riley Securities
G-III Apparel price target raised to $38 from $33 at B. Riley Securities
03/19/21 Barclays
G-III Apparel price target raised to $27 from $24 at Barclays
GIII G-III Apparel
$32.57 /

+0.53 (+1.65%)

GIII G-III Apparel
$32.57 /

+0.53 (+1.65%)

Conference/Events
UBS quantitative analyst to hold analyst/industry conference call » 17:35
06/23/21
06/23
17:35
06/23/21
17:35

Analysts provide Quant…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Artius Acquisition shareholders approve Origin Materials business combination » 17:35
06/23/21
06/23
17:35
06/23/21
17:35
ORGN

Origin Materials

/

+

, AACQ

Artius Acquisition

$9.67 /

+0.325 (+3.48%)

Artius Acquisition (AACQ)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ORGN Origin Materials
/

+

AACQ Artius Acquisition
$9.67 /

+0.325 (+3.48%)

ORGN Origin Materials
/

+

AACQ Artius Acquisition
$9.67 /

+0.325 (+3.48%)

05/03/21 Craig-Hallum
Artius Acquisition initiated with a Buy at Craig-Hallum
AACQ Artius Acquisition
$9.67 /

+0.325 (+3.48%)

Hot Stocks
Casey's General Stores director Bridgewater sells almost $599K in company shares » 17:34
06/23/21
06/23
17:34
06/23/21
17:34
CASY

Casey's General Stores

$198.27 /

-0.51 (-0.26%)

Casey's General…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CASY Casey's General Stores
$198.27 /

-0.51 (-0.26%)

CASY Casey's General Stores
$198.27 /

-0.51 (-0.26%)

06/22/21
Fly Intel: Top five analyst downgrades
06/22/21 Goldman Sachs
Casey's General Stores downgraded to Neutral from Buy at Goldman Sachs
06/22/21 Goldman Sachs
Alimentation Couche-Tard upgraded to Buy from Neutral at Goldman Sachs
06/10/21 Stephens
Casey's General Stores price target lowered to $230 from $250 at Stephens
CASY Casey's General Stores
$198.27 /

-0.51 (-0.26%)

CASY Casey's General Stores
$198.27 /

-0.51 (-0.26%)

CASY Casey's General Stores
$198.27 /

-0.51 (-0.26%)

Conference/Events
FDA Oncologic Drugs Advisory Committee to hold Virtual Meeting » 17:32
06/23/21
06/23
17:32
06/23/21
17:32
INCY

Incyte

$85.11 /

+0.06 (+0.07%)

The Committee discusses…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
INCY Incyte
$85.11 /

+0.06 (+0.07%)

INCY Incyte
$85.11 /

+0.06 (+0.07%)

07:10 Today Benchmark
Incyte's retifanlimab does not seem likely to be approved, says Benchmark
02/10/21 SVB Leerink
Incyte downgraded to Market Perform from Outperform at SVB Leerink
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/07/21 Truist
Incyte initiated with a Buy at Truist
INCY Incyte
$85.11 /

+0.06 (+0.07%)

INCY Incyte
$85.11 /

+0.06 (+0.07%)

INCY Incyte
$85.11 /

+0.06 (+0.07%)

INCY Incyte
$85.11 /

+0.06 (+0.07%)

Hot Stocks
Granite wins $20M bike trail project in California » 17:31
06/23/21
06/23
17:31
06/23/21
17:31
GVA

Granite

$39.80 /

+0.295 (+0.75%)

Granite has been awarded…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GVA Granite
$39.80 /

+0.295 (+0.75%)

GVA Granite
$39.80 /

+0.295 (+0.75%)

04/15/21 DA Davidson
Granite upgraded to Buy from Neutral at DA Davidson
04/15/21 DA Davidson
Granite upgraded to Buy from Neutral at DA Davidson
03/31/21 DA Davidson
Granite price target raised to $35 from $17 at DA Davidson
06/25/20 DA Davidson
Granite Construction price target lowered to $17 from $30 at DA Davidson
GVA Granite
$39.80 /

+0.295 (+0.75%)

GVA Granite
$39.80 /

+0.295 (+0.75%)

Hot Stocks
KB Home raises FY21 housing revenue view to $5.9B-$6.1B from $5.7B-$6.1B » 17:27
06/23/21
06/23
17:27
06/23/21
17:27
KBH

KB Home

$43.35 /

+0.1 (+0.23%)

Raises FY21 average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KBH KB Home
$43.35 /

+0.1 (+0.23%)

KBH KB Home
$43.35 /

+0.1 (+0.23%)

06/15/21 Wedbush
Wedbush sees pullback in KB Home shares as buying opportunity
04/15/21 Wells Fargo
KB Home initiated with an Overweight at Wells Fargo
03/29/21 Argus
KB Home's new orders were 'stellar', says Argus
03/25/21 Keefe Bruyette
KB Home price target raised to $48 from $44 at Keefe Bruyette
KBH KB Home
$43.35 /

+0.1 (+0.23%)

KBH KB Home
$43.35 /

+0.1 (+0.23%)

KBH KB Home
$43.35 /

+0.1 (+0.23%)

KBH KB Home
$43.35 /

+0.1 (+0.23%)

Hot Stocks
KB Home sees Q3 community count up 5%  17:27
06/23/21
06/23
17:27
06/23/21
17:27
KBH

KB Home

$43.35 /

+0.1 (+0.23%)

 
ShowHide Related Items >><<
KBH KB Home
$43.35 /

+0.1 (+0.23%)

KBH KB Home
$43.35 /

+0.1 (+0.23%)

06/15/21 Wedbush
Wedbush sees pullback in KB Home shares as buying opportunity
04/15/21 Wells Fargo
KB Home initiated with an Overweight at Wells Fargo
03/29/21 Argus
KB Home's new orders were 'stellar', says Argus
03/25/21 Keefe Bruyette
KB Home price target raised to $48 from $44 at Keefe Bruyette
KBH KB Home
$43.35 /

+0.1 (+0.23%)

KBH KB Home
$43.35 /

+0.1 (+0.23%)

KBH KB Home
$43.35 /

+0.1 (+0.23%)

KBH KB Home
$43.35 /

+0.1 (+0.23%)

Hot Stocks
KB Home sees Q3 housing revenue $1.5B-$1.58B » 17:24
06/23/21
06/23
17:24
06/23/21
17:24
KBH

KB Home

$43.35 /

+0.1 (+0.23%)

Sees Q3 average selling…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KBH KB Home
$43.35 /

+0.1 (+0.23%)

KBH KB Home
$43.35 /

+0.1 (+0.23%)

06/15/21 Wedbush
Wedbush sees pullback in KB Home shares as buying opportunity
04/15/21 Wells Fargo
KB Home initiated with an Overweight at Wells Fargo
03/29/21 Argus
KB Home's new orders were 'stellar', says Argus
03/25/21 Keefe Bruyette
KB Home price target raised to $48 from $44 at Keefe Bruyette
KBH KB Home
$43.35 /

+0.1 (+0.23%)

KBH KB Home
$43.35 /

+0.1 (+0.23%)

KBH KB Home
$43.35 /

+0.1 (+0.23%)

KBH KB Home
$43.35 /

+0.1 (+0.23%)

Syndicate
NeuBase Therapeutics files to sell 308.6K shares of common stock for holders  17:22
06/23/21
06/23
17:22
06/23/21
17:22
NBSE

NeuBase Therapeutics

$5.05 /

+0.13 (+2.64%)

 
ShowHide Related Items >><<
NBSE NeuBase Therapeutics
$5.05 /

+0.13 (+2.64%)

NBSE NeuBase Therapeutics
$5.05 /

+0.13 (+2.64%)

06/01/21 H.C. Wainwright
NeuBase Therapeutics price target lowered to $15 from $18 at H.C. Wainwright
05/18/21 Chardan
NeuBase Therapeutics named a top pick for 2021 at Chardan
02/12/21 H.C. Wainwright
NeuBase Therapeutics price target raised to $18 from $15 at H.C. Wainwright
NBSE NeuBase Therapeutics
$5.05 /

+0.13 (+2.64%)

  • 22
    Apr
NBSE NeuBase Therapeutics
$5.05 /

+0.13 (+2.64%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.